Psoriasis in the Nails and How It's Treated

Why Nail Psoriasis Is Slow to Treat

Psoriasis in the nails shows up as small pits across the nail surface, yellow-brown "oil-drop" spots under the nail, separation of the nail from the nail bed (onycholysis), and a buildup of thick, crumbly material underneath the nail. Because fingernails take several months to grow out completely and toenails take even longer, any nail psoriasis treatment needs to be judged over months, not weeks — improvement is only visible as new, healthier nail grows in from the base.

That slow timeline is the single most important thing to understand before starting treatment: a topical or injection that is genuinely working can still look unchanged for the first couple of months, simply because the affected nail hasn't grown out yet.

Topical Treatment: The First Step, With Real Limits

Topical corticosteroids and vitamin D analogs are the standard first step across the psoriasis treatment ladder, generally applied to the nail fold and under the nail edge where they can reach 1Ref 1American Academy of Dermatology; National Psoriasis Foundation (2021).Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures.AAD-NPF guideline recommendations for topical psoriasis treatment — corticosteroids for plaques and steroid-sparing agents like vitamin D analogs — applied here to the topical tier for nail psoriasis.. For skin plaques, this tier often works well on its own; for nails, the nail plate itself acts as a physical barrier, which limits how much medication actually reaches the nail matrix and bed where the disease is active.

That's the honest limitation of topical treatment for nail psoriasis: it's still worth trying first, especially for mild involvement of a few nails, but expectations should be modest, and a longer trial than for skin plaques is usually needed before deciding it isn't working.

Steroid Injections Into the Nail Unit

When topical treatment isn't enough, a clinician can inject corticosteroid directly into the nail matrix or proximal nail fold — the tissue that actually produces the nail — delivering medication past the barrier that limits topical treatment. This is a more uncomfortable procedure than applying a cream, typically repeated every several weeks over multiple sessions, and it's usually reserved for a limited number of severely affected nails rather than used across all ten fingers or toes at once.

Results still take months to become visible for the same reason topical treatment does: the improved tissue has to grow out as new nail before it's visible at the free edge.

When Nail Disease Signals It's Time for Systemic Treatment

Extensive nail involvement, nail disease that hasn't responded to topical or injected treatment, or psoriasis affecting several nails alongside significant skin or joint symptoms is generally when systemic treatment enters the conversation. For some, an older, well-established oral option like methotrexate for psoriasis is used before or alongside a biologic, particularly when skin disease is also extensive enough to justify it on its own.

Phototherapy is a mainstay treatment tier for psoriasis more broadly, delivered as narrowband UVB, PUVA, or targeted excimer light 2Ref 2American Academy of Dermatology; National Psoriasis Foundation (2019).Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with phototherapy.AAD-NPF guideline on phototherapy (narrowband/broadband UVB, PUVA, excimer) as a treatment tier for psoriasis; used to note phototherapy's role in the broader ladder even though it reaches nails poorly., but it has limited practical use specifically for nail disease, since light doesn't penetrate the nail plate to reach the matrix and bed the way it reaches exposed skin plaques.

Biologics for Nail Psoriasis

Nail changes often prompt clinicians to ask about joint symptoms too, since national guidelines emphasize screening for psoriatic arthritis as a common, often underrecognized comorbidity of psoriasis 3Ref 3American Academy of Dermatology; National Psoriasis Foundation (2019).Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities.AAD-NPF guideline recommending screening for and awareness of psoriatic arthritis as a comorbidity of psoriasis.. Biologic therapies — TNF, IL-17, IL-23, and IL-12/23 inhibitors — are supported by guideline evidence for psoriasis more broadly and are commonly used for nail disease that hasn't responded to topical or intralesional treatment, particularly when it comes with significant skin involvement 4Ref 4American Academy of Dermatology; National Psoriasis Foundation (2019).Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.AAD-NPF evidence-based recommendations for biologic treatment (TNF, IL-17, IL-23, IL-12/23 inhibitors) of psoriasis, supporting biologics as an escalation tier for nail disease unresponsive to topical or intralesional treatment..

When psoriatic arthritis is also present, national rheumatology and dermatology guidelines recommend TNF-inhibitor biologics over oral small-molecule drugs as a first-line systemic option for active joint disease 5Ref 5Singh JA, Guyatt G, Ogdie A, et al. (2019).2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.ACR/NPF guideline recommending TNF-inhibitor biologics over oral small-molecule drugs as first-line therapy for active psoriatic arthritis., which is one reason nail changes are often the detail that prompts a broader conversation about joint symptoms, not just the nails themselves.

Because nail response still lags behind skin and joint response by the time it takes new nail to grow, a biologic that is working well on the skin can take considerably longer to show visible nail improvement.

Related Places Psoriasis Shows Up

Psoriasis rarely stays confined to one location, and nail changes often accompany disease elsewhere. Scalp psoriasis treatment frequently comes up alongside nail disease, since the scalp is one of the most common sites psoriasis affects outside the nails. Guttate psoriasis — the raindrop psoriasis that follows strep throat in some people — is a distinct pattern of small, drop-like spots rather than nail or plaque disease, though it can occur in the same person over time. Inverse psoriasis, which affects skin folds like the armpits or groin rather than nails or the scalp, is yet another pattern with its own treatment considerations.

Recognizing that psoriasis shows up differently in different locations helps explain why a treatment plan is often built around the whole picture — skin, scalp, nails, and joints together — rather than treating the nails in isolation.

Nail Psoriasis vs. Nail Fungus vs. Nail Lichen Planus

Thickened, discolored, crumbling nails have more than one possible cause, and telling them apart matters because the treatments don't overlap. Nail fungus treatment for a confirmed fungal infection generally follows a nail clipping sent for fungal testing, since a true fungal nail infection needs an oral antifungal course rather than a corticosteroid — ringworm-family fungal infections, including of the nail, are generally treated with antifungal medication rather than an anti-inflammatory one 6Ref 6Centers for Disease Control and Prevention (2024).Treatment of Ringworm.CDC guidance that ringworm-family fungal infections are treated with antifungal medication rather than a corticosteroid, used here to differentiate fungal nail infection from nail psoriasis..

Nail lichen planus is a third possibility: thinning, ridging, and sometimes permanent scarring of the nail from a different inflammatory condition than psoriasis, generally distinguished by its pattern and, when uncertain, by a small nail or skin biopsy. Given how differently each of these three conditions is treated, a nail change that isn't improving with psoriasis-directed treatment is a reasonable prompt to double check the diagnosis rather than simply intensify the same approach.